However, when the visual read method described earlier was applied, scans were visually read as consistent with AD in only ∼20% of patients who died with Braak stage III–IV tau pathology, although this level represents the median Braak stage observed in patients who died at the MCI stage of impairment. The gene discussed is MAPT; the disease is Alzheimer disease.